BioSpace News Archive

MediWound Ltd. today announced positive data from its Phase I/II study to evaluate the safety and efficacy of MW005 in the treatment of low-risk Basal Cell Carcinoma (BCC).

NKGen Biotech Inc. today announced that it will have a poster presentation at the upcoming Alzheimer’s Association International Conference (“AAIC”) to be held in Amsterdam, Netherlands and online from July 16–20, 2023.

BioVie Inc. today announced that a poster detailing the genetic basis for how its drug candidate NE3107 regulated specific genes in a manner significantly correlated with observed cognitive and biomarker improvements will be presented this weekend at the Alzheimer’s Associate’s International Conference (AAIC) to be held in Amsterdam July 16-20, 2023.

Centessa Pharmaceuticals plc today announced the dosing of the first subject in its registrational PRESent-2 study of SerpinPC for the treatment of hemophilia B without inhibitors.

MaxCyte, Inc. today announced the signing of a strategic platform license (SPL) of MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to Vittoria Biotherapeutics.

ReCode Therapeutics announced today the appointment of Erica Jefferson as senior vice president of corporate affairs.

Infinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA ® ) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN).

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced the resignation of Dr. Joel Naor, Chief Medical Officer, effective July 15th, 2023.

Exact Sciences Corp., a leading provider of cancer screening and diagnostic tests, announced that the company plans to release its second quarter 2023 financial results after the close of the U.S. financial markets on August 1, 2023.

NovaBay® Pharmaceuticals, Inc., a company developing and commercializing high-quality eyecare, skincare and wound care products, announces special pricing on Avenova®-branded products to Amazon prime members during Prime Day 2023, being held July 11-12.